Jim Currie and Baber Ghauri talk to Pharm Exec about making connections that resonate with audiences in a digital world.
Jennifer Ringler
Advertisement
Associate Editor, Pharmaceutical Executive Europe
Articles by Jennifer Ringler
Over 25 years the Rx Club Show has reflected dramatic technological changes in advertising. But, as always, the subject comes first, the medium second. So where did the accolades go this year?
The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal.
A Q&A with Andrew Webber, President and CEO of the National Business Coalition on Health
Novartis' Gilenya is a step forward in treating Multiple Sclerosis. But generating increased compliance is another story
Advertisement
Latest Updated Articles
Only Connect: Finding the Key to Digital MarketingPublished: March 7th 2012 | Updated: November 25th 2020
The Rx Club's 25th Anniversary ShowPublished: November 1st 2011 | Updated: November 15th 2020
Patient Advocacy: The Last 30 YearsPublished: October 1st 2011 | Updated: November 26th 2020
- Employers: Fighting Non-Adherence
Published: August 1st 2011 | Updated: November 26th 2020
- Skipping the Needle: Pharm Exec's Brand of the Year
Published: February 1st 2011 | Updated: November 26th 2020
Advertisement
Advertisement
Trending on PharmExec
1
Patent Term Extension: Challenges with Defining and Claiming Approved Biologics
2
Novo Nordisk Invests $506 Million in Ireland Manufacturing Facility Expansion
3
FDA Approves New Indication of Palynziq for Patients 12 Years and Older with Phenylketonuria
4
Real-World Data Brings New Insights to Natural History of Disease Studies
5